Tradestie Institutional Equity Comparison Engine
ABVC vs XFIX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVC Overall Edge
ABVC Captures Institutional Edge (1โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABVC BioPharma, Inc. Common Stock (ABVC) driven by superior Growth & Margin while XFIX counters with relative strength in Momentum & Technical. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus XFIX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XFIX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVC N/M vs XFIX N/M Fwd P/E
Growth & Margin Winner
ABVC
Op Margin 0.0% vs N/A ยท YoY +104.5% vs N/A
Momentum & Technical Winner
XFIX
1Y -68.2% vs -1.1% ยท 52W Pos 7% vs 66%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ABVC
NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap
$23.9M
1M Return
-17.28%
1Y Return
-68.15%
Forward P/E
N/M
Unified AI Score
47.4 / 100
HOLD
Tech 43.0
Fund 50.0
Flow 50.0
Mom 60.0
XFIX
NASDAQ
F/m Opportunistic Income ETF
Institutional Equity
$51.96
-0.04% 1D
Market Cap
N/A
1M Return
-0.01%
1Y Return
-1.15%
Forward P/E
N/M
Unified AI Score
55.5 / 100
HOLD
Tech 25.0
Fund 40.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVC -68.15%
XFIX -1.15%
Spread: +21.69 pp (XFIX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVC TTM Op. Margin: 0.0%
XFIX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs XFIX. Trailing 12-month operating profitability (ABVC 0.0% vs XFIX N/A) and valuation multiples (ABVC N/M vs XFIX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVC | XFIX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $23.9M | N/A | Larger Scale | ABVC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +104.5% | N/A | Higher Growth | ABVC |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | ABVC |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ABVC |
| Return on Equity (ROE) Capital Efficiency | -52.7% | N/A | Higher ROE | ABVC |
| 52-Week Range Position Momentum | 7% ($1โ$3) | 66% ($51โ$53) | Stronger Trend | XFIX |
| Beta / 30D Volatility Risk Regime | 1.24ฮฒ ยท 44% Vol | 0.06ฮฒ ยท 2% Vol | Lower Realized Risk | XFIX |
| Unified Institutional Score Composite Signal | 47.4 / 100 (HOLD) | 55.5 / 100 (HOLD) | Higher Composite | XFIX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVC vs XFIX Buy Guide
ABVC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
XFIX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVC nor XFIX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.